Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Esomeprazole, Aspirin and Rofecoxib in Barrett's Esophagus
NCT00637988Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2002
- Primary completion
- Jun 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of esomeprazole in Barrett's esophagus, sponsored by AstraZeneca. Started Apr 2002; status: completed.
02
Drugs
esomeprazole
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on NCT00637988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637988.